New hope for kids with rare cancer: modified chemo shows promise
NCT ID NCT04881838
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a modified chemotherapy regimen (ALCL99) in 172 Chinese children and teens with high-risk anaplastic large cell lymphoma. The goal is to see if the new plan improves 3-year survival without the cancer coming back, while also tracking side effects. Participants receive the treatment and are compared to past patients who got standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC ANAPLASTIC LARGE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Children's Medical Center
Shanghai, China